Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gastrointestinal Cancers Congress 2024

New targets in immunotherapy beyond CTL4 and PD(L)1

Modulating the microbiome to improve results

Date

28 Jun 2024

Session

New targets in immunotherapy beyond CTL4 and PD(L)1

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Maria Elena Elez Fernandez

Authors

M.E. Elez Fernandez

Author affiliations

  • Vall d'Hebron University Hospital, Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

New targets and new drugs

Presenter: Santiago Ponce Aix

Session: New targets in immunotherapy beyond CTL4 and PD(L)1

Resources:

Slides

Webcast

Q&A

Session: New targets in immunotherapy beyond CTL4 and PD(L)1

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.